SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is generating significant buzz as traders highlight its recent momentum and speculative potential, with the community actively debating whether it can sustain a parabolic run or if liquidity is shifting toward newer meme projects. Enthusiasts are fixated on 'zero-dropping' price action and aggressive buying catalysts, while some skeptical voices warn of the volatility typical of low-cap crypto assets.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as the community maintains a patient, long-term outlook, frequently discussing the project's potential for future growth despite recent price consolidation. Supporters are actively engaging with the ecosystem's utility, including staking options and the health-focused rewards model, while some users look forward to a potential long-term turnaround for the token.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is trending as community members rally behind the belief that increasing on-chain burns and potential regulatory developments could trigger a major recovery. Discussion is centered on high-conviction holders anticipating a supply shock, while active traders debate the impact of upcoming exchange-led token burns and historical price patterns.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is currently generating significant community buzz due to its aggressive development of AI agent infrastructure on the Base ecosystem, with investors closely watching its revenue-linked utility and potential for broader institutional adoption. Traders are actively debating whether to accumulate during current volatility or wait for further price consolidation, while many remain bullish on the long-term potential of its expanding toolset.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in South Korea, Japan, and Turkey, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is trending as market participants analyze potential acquisition rumors involving GameStop and weigh the company's aggressive share repurchase strategy against broader e-commerce sector volatility. Community discussions remain polarized, with many investors debating the feasibility of a high-profile takeover while others focus on technical setups and long-term valuation trends.

Reactive Network is the first parallelized interoperability execution layer, utilising a new form of smart contract we call reactive smart contracts.   Reactive smart contracts are able to react to on-chain events autonomously and execute their own user defined logic to initiate new transactions. This allows a virtually limitless number of use cases to achieve fully decentralized on-chain automation.

Reactive Network

Reactive Network is trending as investors discuss its potential for cross-chain automation and recent integration announcements, while the community focuses on its resilience during market volatility and the upcoming sunset of legacy token migration. Sentiment is high regarding the project's utility and increasing holder count, with many followers anticipating further exchange listings and long-term price appreciation.

What is Chronotech? Chrono.tech provides blockchain-based solutions for recruitment, HR and payment processes, reducing the barriers to accessing work and transferring funds securely in the global labor marketplace. The project’s suite of services - and native governance token TIME - are hosted on multiple blockchains and include LaborX.com, a peer-to-peer freelancer marketplace, TimeX.io, a Plasma-based cryptocurrency exchange; AUDT, an Australian dollar-backed stablecoin; and PaymentX, a crypto invoicing and payroll solution.  TIME token The TIME token is the native token of the Chrono.tech ecosystem and can be used within its products, e.g. to secure premium account status, as well as staking TIME on TimeWarp.finance to receive the revenues generated by all services. In November 2020, the original TIME token was upgraded to the new ERC677 standard, enabling it to be integrated with other DeFi protocols, allowing lower-cost transactions, and providing other advantages, while remaining fully ERC20-compatible. The new TIME 2.0 token contract also included up-to-date metadata about the project.  Chrono.tech products and ecosystem Chrono.tech aims to solve a series of problems in the global recruitment and employment markets. LaborX is Chrono.tech’s freelance work portal. The service allows freelancers and customers to organise work via digital agreements, powered by smart contracts. All payments are escrowed and made in cryptocurrency. Once a job is completed, escrowed payments are released automatically. A dispute resolution service is available in case of disagreement. TimeX is Chrono.tech’s cryptocurrency exchange. TimeX is a hybrid Plasma-based exchange that offers the benefits of both centralised and decentralised technologies. Use of Plasma allows for fast, secure trading of digital assets. The conventional interface provides a user-friendly trading experience. Based in Australia, TimeX is licensed and compliant with rules and best practices required by AUSTRAC, the country’s financial intelligence agency. TimeX is listed on CoinMarketCap https://coinmarketcap.com/exchanges/timex/ TimeWarp is the ecosystem’s DeFi yield farming application where TIME holders can stake their token to earn revenues generated by all products of the Chrono.tech product range. All 100% of revenues generated are being distributed to TIME holders on a weekly basis. AUDT is a stablecoin, hosted on the Ethereum blockchain and backed 1:1 with Australian dollars (AUD). Use of AUDT enables traders to move money into and out of the blockchain ecosystem from an Australian bank account, to store value in AUD on the blockchain and transfer funds anywhere in the world, quickly and easily. AUDT is one of the key fiat currencies traded on TimeX. AUDT is fully compliant with AUSTRAC requirements and undergoes regular audits conducted by a licensed, third party accounting firm. PaymentX is a multi-currency crypto payroll solution that enables individuals as well as businesses to integrate crypto payments into their day-to-day invoice processes. Contractors can submit professional invoices and specify a crypto wallet for payment. Companies can pay multiple invoices with one click, while the software converts the dollar-equivalent amount due into crypto automatically at the point of transaction, avoiding the need for manual calculations. TimeBridge is an in-house developed multi-blockchain tokenbridge that supports multiple blockchains such as Ethereum and BSC. It allows transferring of TIME tokens between networks.

Chronobank

Chronobank is currently generating significant social media conversation driven by its extremely low circulating supply and community-led efforts to create scarcity through buybacks and token burns. Investors are actively debating the asset's potential for volatile price swings, with many highlighting its history of rapid spikes and viewing current price levels as a strategic entry point.

Invesco CurrencyShares Japanese Yen Trust - Invesco CurrencyShares Japanese Yen Trust

Invesco CurrencyShares Japanese Yen Trust

FXY is experiencing significant volatility driven by intense speculation surrounding potential Bank of Japan intervention and the ongoing unwinding of the yen carry trade. The community is actively debating the threat of global financial instability if USD/JPY levels remain elevated, as traders monitor central bank policy signals and geopolitical tensions for further catalysts.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as the community closely monitors legislative progress on the Clarity Act, which many believe will solidify the token's role as a digital commodity for collateralized payments. While some investors are actively accumulating in anticipation of institutional adoption, others remain skeptical, fueling a polarized discussion around long-term utility versus persistent price stagnation.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos (ATOM) is facing significant community debate as holders weigh the potential for long-term staking rewards and technical interoperability against persistent price volatility and concerns regarding inflationary tokenomics. While some investors view the current low valuation as a prime accumulation opportunity, others remain skeptical about the project's ability to maintain its market relevance amidst broader sector shifts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LLY Stock Jumps After Q1 Earnings Beat, 2026 Guidance Raised

LLY jumps after crushing Q1 estimates and raising 2026 outlook, powered by surging Mounjaro and Zepbound sales and strong global demand.

Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 12-Month High  - Still a Buy?

Centessa Pharmaceuticals (NASDAQ:CNTA) Sets New 52-Week High - Still a Buy...

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Short Interest Down 47.5% in April

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Get Free Report) was the recipient of a significant drop in short interest in the month of April. As of April 15th, there was short interest totaling 3,468,688 shares, a drop of 47.5% from the March 31st total of 6,607,633 shares. Based on...

<ul class="summary-bullets"><li>Eli Lilly notched up its sixth acquisition this year with the buyout of Ajax Therapeutics for $2.3 billion.</li><li>Other acquisitions this year include Orna and Kelonia for CAR-T cell therapy.</li><li>In March, Lilly agreed to spend $6.3 billion on Centessa Pharmaceuticals, a firm focused on treating sleep disorders like narcolepsy.</li></ul>Eli Lilly and Company (LLY) is accelerating its 2026 deal spree, notching its sixth acquisition with the buyout of Ajax Therapeutics as it pushes beyond weight-loss drugs to deepen its oncology pipeline.On Monday, Eli Lilly agreed to acquire Ajax Therapeutics in a deal valued at up to $2.3 billion, including milestone payments. The acquisition strengthens Lilly’s presence in blood cancer treatments.Ajax’s lead drug, AJ1-11095, is a next-generation JAK2 inhibitor currently in Phase 1 trials for patients with Myelofibrosis, a type of blood cancer.&nbsp; Lilly said the deal builds on its oncology expertise and aims to expand treatment options for patients with rare blood cancers such as Myelofibrosis and Polycythemia vera.<h2 class="st-heading-2">A Look At Lilly’s Acquisitions</h2>Lilly kicked off the year by agreeing to acquire Ventyx Biosciences, a San Diego-based clinical-stage company developing oral therapies for inflammatory-mediated diseases, in an all-cash deal worth approximately $1.2 billion, a 62% premium to Ventyx’s 30-day average trading price.Ventyx’s pipeline includes NLRP3 inhibitors targeting cardiometabolic, neurodegenerative, and inflammatory conditions.In February, Lilly announced plans to acquire Orna Therapeutics for up to $2.4 billion. Orna’s lead candidate, ORN-252, is a clinical trial-ready CAR-T therapy targeting CD19, a critical cell-surface protein used to treat autoimmune diseases. CAR-T therapies involve delivering genes or genetically engineered cells to help a patient’s immune system fight cancer.In March, Lilly agreed to spend $6.3 billion on Centessa Pharmaceuticals, betting on a portfolio of orexin receptor 2 (OX2R) agonists to treat sleep disorders like narcolepsy. Lilly also acquired CrossBridge Bio for $300 million to gain access to its next-generation cancer treatment, which uses a single antibody to deliver two different cell-killing drugs directly to tumor cells.Earlier this month, Lilly agreed to pay $3.25 billion upfront, and up to $7 billion in total, for Kelonia Therapeutics, which is developing an in vivo cell therapy in early clinical trials for multiple Myeloma. The Kelonia deal marks Lilly's second in vivo CAR-T acquisition of the year.<h2 class="st-heading-2">What Are Retail Traders Saying?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/LLY">LLY</a> on Stocktwits has remained in the ‘bullish’ territory over the past 24 hours, accompanied by ‘high’ message volumes.One user said that big pharma companies like Lilly typically make acquisitions when the risk-reward looks attractive for their pipeline.<stembedurl>https://stocktwits.com/3XL/message/651484609</stembedurl>Another user highlighted the importance of oncology in Lilly’s pipeline, given the massive market size.<stembedurl>https://stocktwits.com/LLYBULL/message/651487002</stembedurl>Overall, LLY shares have been under some selling pressure in 2026, declining nearly 20%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/asbp-stock-jumps-on-buyback-offer/cZBNwxzRePF">ASBP Stock Jumps 21% On Buyback Offer – Retail Believes Every Dip’s A Buying Opportunity</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. (Photo by Scott Olson/Getty Images)

Eli Lilly’s Been On An Acquisition Spree This Year – Here’s A Look At Its Major Deals 

Eli Lilly made several multi-billion dollar acquisitions in 2026, with a strong focus on strengthening its oncology pipeline.

Equity

Should You Buy, Sell or Hold Lilly Stock Before Q1 Earnings?

Lilly heads into Q1 earnings with GLP-1 drugs driving growth. However, pricing pressure, rising costs, and softer Foundayo launch trends cloud the near-term outlook.

38,432 Shares in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Acquired by B. Metzler seel. Sohn & Co. AG

B. Metzler seel. Sohn & Co. AG purchased a new position in Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 38,432 shares of the company's stock, valued at approximately $9...

LLY to Buy Oncology Biotech Kelonia Therapeutics for $7 Billion

Eli Lilly is set to acquire Kelonia Therapeutics in a $7B deal, boosting its genetic medicine platform with a novel in vivo CAR-T therapy for cancer.

Are CNTA, KORE, CWAN Obtaining Fair Deals for their Shareholders?

Are CNTA, KORE, CWAN Obtaining Fair Deals for their Shareholders? Are CNTA, KORE, CWAN Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 20, 2026 Insiders may stand to receive...

Centessa Pharmaceuticals' (CNTA) Equal Weight Rating Reaffirmed at Wells Fargo & Company

Wells Fargo & Company restated an "equal weight" rating and issued a $42.00 target price (up from $35.00) on shares of Centessa Pharmaceuticals in a research report on Monday...

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Consensus Rating of "Hold" by Analysts

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Get Free Report) has earned a consensus recommendation of "Hold" from the fourteen brokerages that are currently covering the firm...

Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.38	--	--	N/A
Q4 '25	-$0.37	--	--	N/A
Q3 '25	-$0.39	-$0.41	-5.57%	MISSED
Q2 '25	-$0.33	-$0.38	-13.84%	MISSED
Q1 '25	-$0.32	-$0.20	38.46%	BEAT

CNTA
Centessa Pharmaceuticals PLC - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest CNTA News

CNTACentessa Pharmaceuticals PLC - ADR